サマリー

エクソソーム診断薬と治療薬の世界市場 2023-2027
Technavio社は、エクソソーム診断薬・治療薬市場をモニターしており、2022年から2027年の間に4億8318万米ドルで成長し、予測期間中のCAGRは21.55%で加速すると予測しています。当レポートでは、エクソソーム診断薬および治療薬市場について、全体的な分析、市場規模と予測、トレンド、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を行っています。
現在の市場シナリオ、最新動向と促進要因、市場全体の環境に関する最新の分析を提供しています。エクソソーム治療薬に関する研究の増加、慢性疾患に対する効果的な薬剤の需要の増加、癌の早期発見への注目の高まりが市場を牽引しています。
Technavioのエクソソーム診断薬・治療薬市場は以下のように区分されます：
エンドユーザー別
- 研究・学術機関
- 製薬・バイオテクノロジー企業
- コマーシャル
アプリケーション別
- ダイアグノスティック
- セラピューティック
ジオグラフィー別
- 北アメリカ
- ヨーロッパ
- 亜細亜
- レスト・オブ・ワールド（ROW）
本調査では、エクソソーム収集における高度な技術が、今後数年間のエクソソーム診断薬・治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、戦略的パートナーシップやM＆A、再生医療への注目の高まりは、市場の大きな需要につながると考えられます。
Technavioは、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。当レポートでは、エクソソームの診断と治療薬市場について、以下の分野を取り上げています：
- エクソソーム診断薬と治療薬市場のサイジング
- エクソソーム診断薬・治療薬市場予測
- エクソソーム診断薬・治療薬市場の産業分析
Technavioの強固なベンダー分析は、クライアントが市場での地位を向上させることを目的としており、これに沿って、本レポートでは、Aethlon Medical Inc.を含むエクソソーム診断および治療薬市場の主要ベンダー数社の詳細分析を提供します、Bio Techne Corp.、BioCat GmbH、BioVision Inc.、Capricor Therapeutics Inc.、Cell Guidance Systems Ltd.、Clara Biotech Inc.、Evox Therapeutics Ltd.、Hologic Inc.、JSR Life Sciences LLC、Lonza Group Ltd., Miltenyi Biotec B.V. and Co.KG、Nanosomix Inc.、NX PharmaGen Inc.、QIAGEN NV、ReNeuron Group plc、Sarepta Therapeutics Inc、Spectris Plc、System Biosciences LLC、Thermo Fisher Scientific Inc.また、エクソソーム診断薬・治療薬市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報が記載されています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/exosome-diagnostics-and-therapeutics-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析によって、複数のソースからのデータを調査、合成、要約する方法で、市場の詳細な画像を提示します。また、業界の主要なインフルエンサーを特定することで、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた詳細なベンダー選択方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global exosome diagnostics and therapeutics market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global exosome diagnostics and therapeutics market 2017 - 2021 ($ million)
o 4.2 End-user Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
o 4.3 Application Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Research and academic institutes - Market size and forecast 2022-2027
o Exhibit 34: Chart on Research and academic institutes - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Research and academic institutes - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Research and academic institutes - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Research and academic institutes - Year-over-year growth 2022-2027 (%)
o 6.4 Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027
o Exhibit 38: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
o 6.5 Commercial - Market size and forecast 2022-2027
o Exhibit 42: Chart on Commercial - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Commercial - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Commercial - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Commercial - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by End-user
o Exhibit 46: Market opportunity by End-user ($ million)
o Exhibit 47: Data Table on Market opportunity by End-user ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 48: Chart on Application - Market share 2022-2027 (%)
o Exhibit 49: Data Table on Application - Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 50: Chart on Comparison by Application
o Exhibit 51: Data Table on Comparison by Application
o 7.3 Diagnostic - Market size and forecast 2022-2027
o Exhibit 52: Chart on Diagnostic - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Diagnostic - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Diagnostic - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Diagnostic - Year-over-year growth 2022-2027 (%)
o 7.4 Therapeutic - Market size and forecast 2022-2027
o Exhibit 56: Chart on Therapeutic - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Therapeutic - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Therapeutic - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Therapeutic - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Application
o Exhibit 60: Market opportunity by Application ($ million)
o Exhibit 61: Data Table on Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share by geography 2022-2027 (%)
o Exhibit 64: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 UK - Market size and forecast 2022-2027
o Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.10 China - Market size and forecast 2022-2027
o Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.11 Japan - Market size and forecast 2022-2027
o Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 103: Market opportunity by geography ($ million)
o Exhibit 104: Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Aethlon Medical Inc.
o Exhibit 111: Aethlon Medical Inc. - Overview
o Exhibit 112: Aethlon Medical Inc. - Business segments
o Exhibit 113: Aethlon Medical Inc. - Key offerings
o Exhibit 114: Aethlon Medical Inc. - Segment focus
o 12.4 Bio Techne Corp.
o Exhibit 115: Bio Techne Corp. - Overview
o Exhibit 116: Bio Techne Corp. - Business segments
o Exhibit 117: Bio Techne Corp. - Key news
o Exhibit 118: Bio Techne Corp. - Key offerings
o Exhibit 119: Bio Techne Corp. - Segment focus
o 12.5 Capricor Therapeutics Inc.
o Exhibit 120: Capricor Therapeutics Inc. - Overview
o Exhibit 121: Capricor Therapeutics Inc. - Product / Service
o Exhibit 122: Capricor Therapeutics Inc. - Key offerings
o 12.6 Evox Therapeutics Ltd.
o Exhibit 123: Evox Therapeutics Ltd. - Overview
o Exhibit 124: Evox Therapeutics Ltd. - Product / Service
o Exhibit 125: Evox Therapeutics Ltd. - Key offerings
o 12.7 Hologic Inc.
o Exhibit 126: Hologic Inc. - Overview
o Exhibit 127: Hologic Inc. - Business segments
o Exhibit 128: Hologic Inc. - Key news
o Exhibit 129: Hologic Inc. - Key offerings
o Exhibit 130: Hologic Inc. - Segment focus
o 12.8 JSR Life Sciences LLC
o Exhibit 131: JSR Life Sciences LLC - Overview
o Exhibit 132: JSR Life Sciences LLC - Product / Service
o Exhibit 133: JSR Life Sciences LLC - Key offerings
o 12.9 Lonza Group Ltd.
o Exhibit 134: Lonza Group Ltd. - Overview
o Exhibit 135: Lonza Group Ltd. - Business segments
o Exhibit 136: Lonza Group Ltd. - Key news
o Exhibit 137: Lonza Group Ltd. - Key offerings
o Exhibit 138: Lonza Group Ltd. - Segment focus
o 12.10 Miltenyi Biotec B.V. and Co. KG
o Exhibit 139: Miltenyi Biotec B.V. and Co. KG - Overview
o Exhibit 140: Miltenyi Biotec B.V. and Co. KG - Product / Service
o Exhibit 141: Miltenyi Biotec B.V. and Co. KG - Key offerings
o 12.11 Nanosomix Inc.
o Exhibit 142: Nanosomix Inc. - Overview
o Exhibit 143: Nanosomix Inc. - Product / Service
o Exhibit 144: Nanosomix Inc. - Key offerings
o 12.12 NX PharmaGen Inc.
o Exhibit 145: NX PharmaGen Inc. - Overview
o Exhibit 146: NX PharmaGen Inc. - Product / Service
o Exhibit 147: NX PharmaGen Inc. - Key offerings
o 12.13 QIAGEN NV
o Exhibit 148: QIAGEN NV - Overview
o Exhibit 149: QIAGEN NV - Product / Service
o Exhibit 150: QIAGEN NV - Key news
o Exhibit 151: QIAGEN NV - Key offerings
o 12.14 Sarepta Therapeutics Inc
o Exhibit 152: Sarepta Therapeutics Inc - Overview
o Exhibit 153: Sarepta Therapeutics Inc - Product / Service
o Exhibit 154: Sarepta Therapeutics Inc - Key offerings
o 12.15 Spectris Plc
o Exhibit 155: Spectris Plc - Overview
o Exhibit 156: Spectris Plc - Business segments
o Exhibit 157: Spectris Plc - Key news
o Exhibit 158: Spectris Plc - Key offerings
o Exhibit 159: Spectris Plc - Segment focus
o 12.16 System Biosciences LLC
o Exhibit 160: System Biosciences LLC - Overview
o Exhibit 161: System Biosciences LLC - Product / Service
o Exhibit 162: System Biosciences LLC - Key offerings
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 163: Thermo Fisher Scientific Inc. - Overview
o Exhibit 164: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 165: Thermo Fisher Scientific Inc. - Key news
o Exhibit 166: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 167: Thermo Fisher Scientific Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 168: Inclusions checklist
o Exhibit 169: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 170: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 171: Research methodology
o Exhibit 172: Validation techniques employed for market sizing
o Exhibit 173: Information sources
o 13.5 List of abbreviations
o Exhibit 174: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global exosome diagnostics and therapeutics market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on End-user - Market share 2022-2027 (%)
Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Research and academic institutes - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Research and academic institutes - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Research and academic institutes - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Research and academic institutes - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Commercial - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Commercial - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Commercial - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Commercial - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by End-user ($ million)
Exhibits47: Data Table on Market opportunity by End-user ($ million)
Exhibits48: Chart on Application - Market share 2022-2027 (%)
Exhibits49: Data Table on Application - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Application
Exhibits51: Data Table on Comparison by Application
Exhibits52: Chart on Diagnostic - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Diagnostic - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Diagnostic - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Diagnostic - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Therapeutic - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Therapeutic - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Therapeutic - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Therapeutic - Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Application ($ million)
Exhibits61: Data Table on Market opportunity by Application ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share by geography 2022-2027 (%)
Exhibits64: Data Table on Market share by geography 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity by geography ($ million)
Exhibits104: Data Tables on Market opportunity by geography ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Aethlon Medical Inc. - Overview
Exhibits112: Aethlon Medical Inc. - Business segments
Exhibits113: Aethlon Medical Inc. - Key offerings
Exhibits114: Aethlon Medical Inc. - Segment focus
Exhibits115: Bio Techne Corp. - Overview
Exhibits116: Bio Techne Corp. - Business segments
Exhibits117: Bio Techne Corp. - Key news
Exhibits118: Bio Techne Corp. - Key offerings
Exhibits119: Bio Techne Corp. - Segment focus
Exhibits120: Capricor Therapeutics Inc. - Overview
Exhibits121: Capricor Therapeutics Inc. - Product / Service
Exhibits122: Capricor Therapeutics Inc. - Key offerings
Exhibits123: Evox Therapeutics Ltd. - Overview
Exhibits124: Evox Therapeutics Ltd. - Product / Service
Exhibits125: Evox Therapeutics Ltd. - Key offerings
Exhibits126: Hologic Inc. - Overview
Exhibits127: Hologic Inc. - Business segments
Exhibits128: Hologic Inc. - Key news
Exhibits129: Hologic Inc. - Key offerings
Exhibits130: Hologic Inc. - Segment focus
Exhibits131: JSR Life Sciences LLC - Overview
Exhibits132: JSR Life Sciences LLC - Product / Service
Exhibits133: JSR Life Sciences LLC - Key offerings
Exhibits134: Lonza Group Ltd. - Overview
Exhibits135: Lonza Group Ltd. - Business segments
Exhibits136: Lonza Group Ltd. - Key news
Exhibits137: Lonza Group Ltd. - Key offerings
Exhibits138: Lonza Group Ltd. - Segment focus
Exhibits139: Miltenyi Biotec B.V. and Co. KG - Overview
Exhibits140: Miltenyi Biotec B.V. and Co. KG - Product / Service
Exhibits141: Miltenyi Biotec B.V. and Co. KG - Key offerings
Exhibits142: Nanosomix Inc. - Overview
Exhibits143: Nanosomix Inc. - Product / Service
Exhibits144: Nanosomix Inc. - Key offerings
Exhibits145: NX PharmaGen Inc. - Overview
Exhibits146: NX PharmaGen Inc. - Product / Service
Exhibits147: NX PharmaGen Inc. - Key offerings
Exhibits148: QIAGEN NV - Overview
Exhibits149: QIAGEN NV - Product / Service
Exhibits150: QIAGEN NV - Key news
Exhibits151: QIAGEN NV - Key offerings
Exhibits152: Sarepta Therapeutics Inc - Overview
Exhibits153: Sarepta Therapeutics Inc - Product / Service
Exhibits154: Sarepta Therapeutics Inc - Key offerings
Exhibits155: Spectris Plc - Overview
Exhibits156: Spectris Plc - Business segments
Exhibits157: Spectris Plc - Key news
Exhibits158: Spectris Plc - Key offerings
Exhibits159: Spectris Plc - Segment focus
Exhibits160: System Biosciences LLC - Overview
Exhibits161: System Biosciences LLC - Product / Service
Exhibits162: System Biosciences LLC - Key offerings
Exhibits163: Thermo Fisher Scientific Inc. - Overview
Exhibits164: Thermo Fisher Scientific Inc. - Business segments
Exhibits165: Thermo Fisher Scientific Inc. - Key news
Exhibits166: Thermo Fisher Scientific Inc. - Key offerings
Exhibits167: Thermo Fisher Scientific Inc. - Segment focus
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations